Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應用
Benzoylmetronildazole is a new class of antiglycation agents used to treat diabetes mellitus. Benzoylmetronildazole is also a derivative of Metronidazole (M338880), an antibacterial in the treatment of rosacea.
參考文獻
Zeb, A., et al.: Med. Chem., 8, 846 (2012); Kumari, N., et al.: Curr. Drug. Deliv., 9, 74 (2012); Elosta, A., et al.: Curr. DIabetes. Rev., 8, 92 (2012);
滬ICP備17019645號
400-821-0725
